KU 136 (Omeprazole delayed release 40 mg)
Pill imprint KU 136 has been identified as Omeprazole delayed release 40 mg.
Omeprazole is used in the treatment of gerd; barrett's esophagus; erosive esophagitis; gastritis/duodenitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 40 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 40 mg
- 3.00 mm
- Rx and/or OTC
sodium lauryl sulfate
ferric oxide yellow
methacrylic acid - methyl methacrylate copolymer (1:1)
aluminum chlorohydrex propylene glycol
|NDC Code||Manufacturer / Repackager|
|63739-0445||McKesson Packaging Services|
|54868-5987||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about omeprazole
- Omeprazole delayed-release capsules
- Omeprazole delayed-release oral suspension
- Omeprazole delayed-release tablets
- Omeprazole magnesium delayed-release capsules and tablets
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.